Plans designed by Gensler for a £1bn cancer research and treatment centre in south London have been submitted for planning by developers Aviva Capital Partners and Socius.
The 1 million sq ft scheme would be built on a 12-acre site at the London Cancer Hub, which already contains The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust’s Sutton treatment centre.
Aviva and Socius are working with landowner the London Borough of Sutton on the project, which will contain research and laboratory space for life sciences companies, academic researchers and clinicians.
A series of proposed buildings up to nine storeys in height would range from large-scale facilities for global pharmaceutical and life sciences companies through to smaller lab and incubator spaces for start-ups.
The scheme would also contain restaurants and cafes, a creche, an educational space and affordable homes for 220 key workers.
Councillor Barry Lewis, leader of the London Borough of Sutton, said: “The London Cancer Hub will position Sutton as London’s global centre for oncology.
“Already recognised as a leading life science cluster in the capital, the site’s uniqueness lies in its current delivery of world-class cancer research, discoveries, and treatment all within a single location.”
Aviva and Socius are hoping for a planning committee date this autumn with construction scheduled to start next year.
The project team also includes structural engineer Arup and planning consultant Savills.
No comments yet